Our Flagship Product: VECanDx ELISA Test
For the detection of bladder cancer non-invasively in hematuria and recurrent bladder cancer patients.
Enzyme-linked immunosorbent assay (ELISA) is routinely used in hospitals for detection and quantification of biomarkers specific to various diseases using patient samples. Our ELISA IVD test will employ standard ELISA procedures that are well established in numerous hospitals for sensitive detection of the five bladder cancer biomarkers patented by BioCheetah.
We utilise immunoassays to detect five specific protein biomarkers that are present exclusively in bladder cancer. Thus, the multiplex biomarker panel offers unprecedented accuracy for the diagnosis of bladder cancer and provides the prospect for a non-invasive way to detect bladder cancer in patients.